Clinical trial
Comparison Study of Efficacy and Safety of Levetiracetam Versus Valproate in Treatment of Idiopathic Generalized Tonic-clonic Seizures
NCT03940326 is registered in ClinicalTrials.gov with Mazandaran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Study of Efficacy and Safety of Levetiracetam Versus Valproate in Treatment of Idiopathic Generalized Tonic-clonic Seizures
- Lead sponsor
- Mazandaran University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 1, 2018
- Completion date
- December 1, 2019
- Enrollment
- 103 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy, idiopathic generalized